Clinical Trials List
2014-06-01 - 2015-12-31
Phase III
Terminated7
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Yu-Chao Lin Division of General Internal Medicine
- Bing-Ru Wu Division of General Internal Medicine
- Chen Chia-Hung Division of General Internal Medicine
- Shuo-Chueh Chen Division of General Internal Medicine
- Wei-Chun Chen Division of General Internal Medicine
- 梁信杰 Division of General Internal Medicine
- Chih-Ching Yen Division of General Internal Medicine
- Chih-Yen Tu Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 張晟瑜 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jen-Yu Hung Division of Thoracic Medicine
- Chau-Chyun Sheu Division of Thoracic Medicine
- jong rung Tsai Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 覃俊士 Division of Thoracic Medicine
- 王振宇 Division of Thoracic Medicine
- Wei- Chang Huang Division of Thoracic Medicine
- Ming -Cheng Chan Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
454 participants
